Community Health Worker Support for Postpartum Hypertension
(AW2H Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
High blood pressure during or after pregnancy (such as preeclampsia, gestational hypertension, eclampsia, or Hemolysis, Elevated Liver enzymes, and Low Platelet (HELLP) syndrome) raises a mother's risk of heart disease later in life. Many patients do not return for follow-up care after delivery, missing a key window to protect their heart health. The Alabama Womb to Heart Solution (AW2H) trial will test whether pairing postpartum patients with a trained community health worker (CHW) for 6 months lowers blood pressure compared with usual care.
A total of 174 postpartum patients who had pregnancy-associated hypertension or stage 2 high blood pressure will be randomly assigned (1:1) to usual care or usual care plus the AW2H CHW program. All participants receive education on measuring their own blood pressure and a pregnancy-validated home blood pressure monitor. Participants in the CHW group are also contacted regularly by a CHW for 6 months. CHWs coach home blood pressure monitoring, support taking blood pressure medications as prescribed, encourage heart-healthy habits based on the American Heart Association's Life's Essential 8 (LE8), help schedule a primary care visit, provide mother-baby education (such as safe sleep and immunizations), and offer emotional support.
The main outcome is systolic blood pressure 6 months after enrollment, measured at home with the study-provided monitor while a research coordinator observes in person or by video/phone. The study will also look at diastolic blood pressure and whether participants scheduled a primary care visit. Interviews and focus groups will explore participant, CHW, and provider experiences with the program.
Who Is on the Research Team?
Jesse Rattan, PhD, MPH, RN
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for English-speaking women aged 16-56 who delivered at UAB Hospital in the last six weeks (including pregnancy loss) and had high blood pressure during or after pregnancy. They must not be incarcerated, already in similar studies, or unwilling to be randomly assigned.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive usual care or usual care plus the AW2H CHW program for 6 months
Follow-up
Participants are monitored for systolic and diastolic blood pressure, and integration into primary care is assessed
What Are the Treatments Tested in This Trial?
Interventions
- Alabama Womb to Heart Solution (AW2H) Community Health Worker (CHW) Program
Trial Overview
The study compares usual postpartum care with self-blood pressure monitoring versus the same care plus regular support from a trained community health worker for six months. Participants are randomly placed into one of these two groups.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Usual care (as in Arm 1) plus enrollment in the Alabama Womb to Heart Solution (AW2H) community health worker (CHW) program for 6 months.
Cardiovascular disease (CVD)-prevention education before hospital discharge from the delivery-associated hospitalization, including brief self-measured blood pressure (BP) education, a pregnancy-validated iHealth BP Cuff Kit, and written education on hypertensive disorders of pregnancy, long-term cardiovascular risk, and postpartum danger signs.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator
ConnectionHealth
Collaborator
Preeclampsia Foundation
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.